Nuchal Fold in a Newborn: What It Is and What It Means

A nuchal fold refers to the soft tissue at the back of a fetus’s or newborn’s neck, and its thickness is one of the most well-studied prenatal markers for chromosomal conditions such as Down syndrome. Measured by ultrasound during the second trimester of pregnancy, a thickened nuchal fold prompts further testing but does not, on its own, diagnose any condition. The term sometimes surfaces after birth when a pediatrician notices extra skin folds at the back of a baby’s neck, though most of the clinical significance centers on what the measurement reveals before delivery.

Nuchal Fold Versus Nuchal Translucency

Parents often hear both “nuchal fold” and “nuchal translucency” and assume they mean the same thing. They don’t. Nuchal translucency (NT) is a pocket of fluid measured at the back of the fetal neck during the first trimester, typically between 11 and 14 weeks of pregnancy. Nuchal fold (NF) thickness is a separate measurement taken later, usually during the anatomy scan between about 15 and 24 weeks, and it captures the thickness of skin and soft tissue rather than just a fluid space. Research comparing the two in the same fetuses found no statistically significant correlation between the early NT measurement and the later NF measurement, even among fetuses with Down syndrome.¹ In other words, a normal first-trimester NT does not guarantee a normal second-trimester nuchal fold, and vice versa. Each measurement captures something different at a different stage of development.

How the Nuchal Fold Is Measured

During a second-trimester ultrasound, the sonographer finds a specific cross-sectional view of the fetal head and measures the distance from the outer edge of the skull bone to the outer edge of the overlying skin at the back of the head.² A measurement of 6 mm or more is the most commonly used threshold for calling the nuchal fold “thickened,” and studies have found this cutoff holds up well for pregnancies between 20 and 24 weeks.³ Before 20 weeks, the picture is a bit different. Research suggests that between 14 and 18 weeks, a lower threshold of 5 mm may be more appropriate for flagging potential problems.⁴

This is where gestational age really matters. A fold that measures 5 mm at 16 weeks means something different than one measuring 5 mm at 23 weeks, because the tissue naturally gets thicker as the fetus grows. Some researchers have argued that using population-based percentile charts for each week of pregnancy, rather than a single 6 mm cutoff applied across the board, would reduce false alarms. One large study of over 2,300 normal pregnancies found that the 95th percentile for nuchal fold thickness ranged from about 4.7 mm at 15 weeks to 6.8 mm at 24 weeks, and using a blanket 6 mm cutoff produced false-positive rates as high as 37 percent at later gestational ages.⁵

The Link to Down Syndrome

The nuchal fold was first identified as a marker for Down syndrome in the mid-1980s, making it one of the earliest ultrasound “soft markers” used in prenatal screening.⁶ Decades of research since have consistently shown that fetuses with trisomy 21 tend to have thicker nuchal folds than unaffected fetuses. In one study, the average nuchal fold in fetuses with Down syndrome was about 4.7 mm, compared with roughly 3.2 mm in chromosomally normal fetuses, and the association between a thick nuchal fold and trisomy 21 was stronger than any other individual ultrasound marker.⁷

That said, the measurement alone is not a diagnosis. Using a 5 mm threshold in earlier pregnancies detected about 42 percent of Down syndrome cases, meaning more than half were missed.⁴ The 6 mm threshold at later gestational ages performs better, picking up a larger share, but no single cutoff catches every case. This is exactly why clinicians combine nuchal fold measurements with other factors, including maternal age, blood-test results, and additional ultrasound findings, to estimate the overall likelihood of a chromosomal condition. Combining nuchal translucency with maternal age, for example, has been shown to detect a very high proportion of Down syndrome pregnancies, though at the cost of a substantial testing rate.⁸

Other Chromosomal Conditions

Down syndrome gets the most attention, but an unusually thick nuchal region can also flag other chromosomal conditions. Turner syndrome, in which a female fetus has only one X chromosome instead of two, is one of the most common. Turner syndrome is closely linked with cystic hygroma, a fluid-filled swelling at the back of the neck that represents a more dramatic version of nuchal thickening. Turner syndrome is in fact the largest single cause associated with cystic hygroma in the fetal neck.⁹

Why does this happen? Research into the skin and connective tissue of chromosomally abnormal fetuses has pointed to changes in the extracellular matrix, the scaffolding between cells that helps control how fluid moves through tissues. In Turner syndrome fetuses, certain structural molecules in the nuchal skin appear to be abnormally distributed, and a protein called biglycan, which is coded by a gene on the X chromosome, seems to be underexpressed when there is only one X chromosome. This altered tissue composition likely contributes to the fluid buildup that shows up as increased nuchal thickness on ultrasound.¹⁰ One hypothesis suggests that excess vascular growth factor produced in the walls of distended fluid sacs may contribute to other features of Turner syndrome beyond the neck swelling itself.¹¹

Trisomy 18, trisomy 13, and certain rarer chromosomal rearrangements have also been found in fetuses with thickened nuchal folds. In one study of 72 fetuses with a thick nuchal fold, the group where the thickening was combined with structural abnormalities visible on ultrasound had a chromosomal defect rate of about 35 percent. That group included cases of trisomy 21, Turner syndrome, trisomy 13, and several smaller-scale chromosomal changes called pathogenic copy number variants.¹²

Heart Defects Even When Chromosomes Are Normal

One finding that surprises many parents is that increased nuchal thickness is associated with higher rates of congenital heart defects, independent of any chromosomal problem. Even when a fetus’s chromosomes come back completely normal, a thicker-than-average nuchal measurement increases the chance that a significant heart defect is present. A meta-analysis pooling data from over 200,000 fetuses across 20 studies found that a nuchal translucency above the 95th percentile identified roughly 44 percent of major congenital heart defects, with a specificity of about 95 percent.¹³

The relationship follows a dose-response pattern: the thicker the measurement, the higher the risk. In one large study of chromosomally normal fetuses, those with a nuchal translucency of 2.5 to 3.4 mm had a heart defect rate of about 2.5 percent, while those measuring 3.5 mm or above had a rate around 7 percent.¹⁴ Another study tracked the numbers more granularly and showed that the prevalence of major cardiac defects climbed from about 5 per 1,000 in fetuses with nuchal thickness below the median to roughly 127 per 1,000 in those measuring 5.5 mm or more.¹⁵ This is the reason why a thick nuchal measurement often leads to a referral for a detailed fetal echocardiogram, even when chromosome testing returns normal results.

Non-Chromosomal Genetic Syndromes

Beyond chromosomal conditions and heart defects, increased nuchal fluid is sometimes the first sign of a single-gene disorder. Noonan syndrome is the most frequently discussed in this context. It is a genetic condition that affects growth, heart development, and facial features, and it is caused by mutations in several genes involved in cell signaling pathways, not by a missing or extra chromosome. Because standard chromosome testing (karyotyping) comes back normal in Noonan syndrome, clinical guidelines advise that Noonan syndrome should be considered whenever a fetus shows increased nuchal fluid, fluid collections around the lungs or body, or excess amniotic fluid with a normal karyotype.¹⁶ Identifying this possibility matters because it changes what genetic tests are offered and how the pregnancy and early newborn period are managed.

When a Thick Nuchal Fold Stands Alone

Many parents receive the news of a thickened nuchal fold alongside an otherwise completely normal-looking ultrasound. This scenario, called an “isolated” finding, carries a very different risk profile than when the thick fold appears alongside visible structural problems. In the same study that found a 35 percent chromosomal defect rate when the fold was combined with structural malformations, isolated thickened nuchal folds carried a chromosomal defect rate of only about 3.7 percent.¹² When the thick fold appeared alongside other soft markers alone (minor ultrasound variations that are common in healthy fetuses), the chromosomal defect rate dropped to zero in that cohort.

The outcomes for isolated findings are generally reassuring. In that study’s group of isolated cases, nearly all babies without structural malformations were born alive and had normal physical examinations at least one year after birth.¹⁷ Research looking at first-trimester nuchal translucency paints a similar picture: when an isolated, moderately increased measurement regresses by the second trimester and no harmful genetic variant is found, outcomes tend to be favorable.¹⁸

Thickness still matters, though, even in the absence of other findings. The same study noted that rates of structural malformations and adverse outcomes rose when the nuchal fold measured 10 mm or more, compared with measurements in the 5 to 7.9 mm or 8 to 9.9 mm ranges.¹² So even when no other red flags are present, the sheer magnitude of the measurement influences how aggressively clinicians will pursue further evaluation.

What Happens After the Finding

If your baby’s nuchal fold measures above the threshold during an ultrasound, the next steps typically unfold in layers. The first is usually a careful review of the rest of the anatomy scan. Clinicians look at the heart, brain, spine, kidneys, limbs, and other organs for any structural abnormalities, because the combination of a thick fold with visible anomalies dramatically changes the risk estimate, as described above.

If chromosomal testing hasn’t been done, your provider will likely offer it. This might take the form of cell-free DNA screening (a blood test), or it might involve a diagnostic procedure such as amniocentesis, which analyzes fetal cells from the amniotic fluid and can detect both full-chromosome abnormalities and smaller genetic changes called copy number variants. In one study, five of the twelve chromosomal defects found among fetuses with thickened nuchal folds were these smaller-scale copy number variants, the kind that standard karyotyping can miss but chromosomal microarray analysis picks up.¹² This is one reason many centers now use microarray testing rather than traditional karyotyping alone when evaluating a thickened nuchal fold.

A fetal echocardiogram is commonly recommended as well, given the link between increased nuchal thickness and congenital heart defects even when chromosomes are normal. This specialized ultrasound of the fetal heart provides much more detail than the standard anatomy scan. Depending on the full clinical picture, additional genetic testing for conditions like Noonan syndrome may also be discussed, especially if chromosomal results come back normal but suspicion remains.

The Emotional Weight of an Abnormal Measurement

For parents, hearing that a measurement on their baby’s ultrasound is outside the normal range can be terrifying, especially when the word “Down syndrome” or “heart defect” follows. The anxiety is real and well documented. Research into the psychological impact of nuchal screening has found that receiving a reassuring result after an initially concerning finding significantly reduces anxiety and the feeling of being torn about decisions.¹⁹ But that intervening period of uncertainty can be deeply stressful.

It helps to keep perspective on what a screening marker actually is. A thick nuchal fold raises a statistical flag. It does not tell you what, if anything, is wrong. Most fetuses with a mildly thickened nuchal fold and no other abnormalities are born healthy. Even among those with more significantly elevated measurements, many have normal chromosomes and no detectable condition. The measurement funnels you toward more definitive tests that can either rule out the feared diagnoses or identify them early enough to plan appropriately.

Nuchal Skin at Birth

While the nuchal fold is overwhelmingly a prenatal concept, occasionally the term comes up after delivery. A newborn with Down syndrome may have a visibly loose fold of skin at the back of the neck, which reflects the same underlying tissue changes that produced the thickened measurement on prenatal ultrasound. Pediatricians may note this as one of several physical features they evaluate in the newborn period, alongside facial appearance, muscle tone, palm creases, and other characteristics that together raise suspicion for a chromosomal condition.

A noticeable skin fold at the back of a healthy newborn’s neck, especially in babies born with a bit of extra weight or those who are very flexible, is usually just normal baby anatomy and not a cause for concern. The clinical significance only emerges when it appears alongside other findings that fit a recognizable pattern. If your pediatrician examines the baby and is not concerned, the fold itself is not a problem worth worrying about.

How Screening Has Evolved

The nuchal fold occupies an interesting place in the history of prenatal screening. It was one of the first second-trimester ultrasound markers tied to Down syndrome, identified in 1985. Through the 1990s, the “genetic sonogram” combined the nuchal fold with other soft markers and second-trimester blood tests to improve detection rates while allowing women with normal-looking ultrasounds to be reassured that their risk was lower.⁶ Since then, first-trimester screening with nuchal translucency largely replaced second-trimester soft markers as the primary approach, and cell-free DNA testing has shifted the landscape again by offering high sensitivity for major chromosomal conditions from a simple maternal blood draw.

Despite these newer technologies, the second-trimester nuchal fold measurement has not disappeared. It remains relevant when women present for care late in the first trimester, when first-trimester screening was not performed, or when additional information is needed to refine risk estimates from earlier testing. It also retains its role in flagging heart defects, something cell-free DNA tests do not address. The measurement has gone from being the front line of screening to being one useful piece of a much larger diagnostic puzzle, but it still carries real clinical weight when it shows up on your scan report.

1
Wiley Online Library. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses
2
PubMed Central. Comparison of Fetal Nuchal Fold Thickness Measurements by Two- and Three-Dimensional Ultrasonography (3DXI Multislice View)
3
PubMed. Impact of gestational age on nuchal fold thickness in the second trimester
4
American Journal of Obstetrics and Gynecology. Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome
5
PubMed Central. Fetal nuchal skin-fold thickness during the 2nd trimester of pregnancy
6
Wiley Online Library / Prenatal Diagnosis. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice
7
American Journal of Obstetrics & Gynecology. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome
8
PubMed. Screening for Down’s syndrome by fetal nuchal translucency measurement in a general obstetric population
9
PubMed. Posterior nuchal cystic hygroma
10
Human Reproduction. Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency
11
PubMed. Potential involvement of vascular endothelial growth factor in pathophysiology of Turner syndrome
12
PubMed Central. Prenatal diagnosis and pregnancy outcome analysis of thickened nuchal fold in the second trimester
13
PubMed. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis
14
PubMed. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype
15
PubMed. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype
16
PubMed Central. Noonan syndrome
17
PubMed Central. Prenatal diagnosis and pregnancy outcome analysis of thickened nuchal fold in the second trimester – Section: Discussion
18
PubMed. Cohort of increased nuchal translucency in the first trimester without pathogenic variant on chromosomal microarray analysis: Outcomes for fetuses, neonates, and at the age of 2
19
University of Toronto TSpace. Psychosocial aspects of decision making for prenatal screening: nuchal translucency scanning as a new screening alternative